Bristol-Myers Squibb raised FY 2025 guidance, with operating EPS targeted at $6.40–$6.60 and net sales above consensus. Click here to find out why BMY is a Buy.

Ichor Holdings (ICHR) is rated BUY, with fundamentals expected to improve in 2026 and a bottoming share price creating an attractive entry point. ICHR's new CEO is focused on operational discipline ...

Need a better way to plan projects? Discover mind map examples that help you visually organize tasks, ideas, and strategies ...

Full-Year Guidance Maintained -- Management reaffirmed guidance for organic revenue growth of 1%-4%, adjusted EBITDA growth ...

D-Wave Quantum ( QBTS 2.68%), a provider of quantum computing services, went public by merging with a special purpose ...

The Beneish M-Score is an effective, quick-screening tool to detect frauds. Developed by Professor Messod Beneish, this mathematical model crunches key financial ratios to provide a preliminary ...

Since the launch of ChatGPT in November 2022, the Magnificent 7 companies have accounted for more than half the S&P 500 Index ...

Presenting your user experience (UX) work is not just a meeting on the calendar; it is a skill that can either save or ruin a project. It is at this point that ...

Perhaps no singular event influenced the Orange County community's experience in 2025 more than Tropical Storm Chantal's ...

Explore the essential role of India’s market infrastructure institutions (MIIs). As demat accounts cross the 16-crore ...